Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients - Yahoo Finance
Submitted by Anonymous (not verified) on Mon, 11/20/2023 - 13:00
